Johnson & Johnson Aligns With HP To Create Personalized Healthcare Solutions

Johnson & Johnson (NYSE: JNJ) revealed that its subsidiary and HP Inc. (NYSE: HPQ) subsidiary aligned to create personalized healthcare solution with the help of 3D printing technologies. According to the companies, the collaboration was focused on using 3D printing technologies to reduce costs.

The two firms indicated that by aligning, they could combine their scientific, clinical, material science and technological expertise, and deep insights to develop products and solutions that could be manufactured quickly and customized to the needs of an individual patient or consumer.

Johnson & Johnson and HP said that in the near-term, the alliance would focus on personalization of instrumentation and software for patient-specific healthcare devices. Both the companies' believe that 3D printing technology would lead to innovation in areas like orthopaedics, eye health and consumer products, among others.

The healthcare firm's Chairman, Sandra Peterson, commented, "The intersection of technology and health care is spurring innovation that will have a profound impact on patients and consumers all over the world. Combined with advances in data mining and software, 3D printing could enable distributed manufacturing models and patient-specific products, therapies and solutions that deliver better outcomes, better economics and improved global accessibility. This collaboration with HP Inc. exemplifies our commitment to harnessing new technology to improve outcomes and reduce costs across the health continuum."

Similarly, HP's 3D Printing unit President, Stephen Nigro, said, "Advances in 3D printing technology have the potential to break historical paradigms of health care delivery in ways that are not feasible in traditional manufacturing processes. Together with Johnson & Johnson we have the potential to create opportunities and innovations in health care to improve patients' lives that neither company could develop alone."

The companies indicated that the collaboration has already started, with teams of experts from both the firms working together.

See more from Benzinga

© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Advertisement